ymbiosciences6k_12032012.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
___________________
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November 2012
 
Commission File Number 1-32186
___________________
 
YM BioSciences Inc.
(Translation of registrant's name into English)
 
Suite 400, Building 11
5045 Orbitor Drive
Mississauga, Ontario
Canada  L4W 4Y4
(Address of principal executive offices)
___________________
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)
Form 20-F o                                                     Form 40-F þ
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  o
 
 
 

 
 
 
 
 
DOCUMENTS FILED

See the Exhibit Index hereto for a list of the documents filed herewith and forming a part of this Form 6-K.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
 YM BIOSCIENCES INC.
   
 
 By:  /s/ Leonard Vernon            
 
 Name:  Leonard Vernon
 
 Title:   Vice President, Finance & Administration
 

 
Date:  December 3, 2012

 
 
 
 
 
 
 

EXHIBIT INDEX

Exhibit
Description
   
99.1
Report of Voting Results